Eiichi Araki et al Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial Subjects--Topical Terms: Computer science, information & general works